At the beginning of the COVID-19 pandemic, the need for hospital rooms saw several modular home factories step up to provide the engineering and production of modular care units to isolate its victims. Among those was VBC modular who formed the MMC which provided a plan for modular factories across the US to join together to help hospitals quickly provide additional beds.
It was successful and proved that our industry can work together to meet almost any need our country encounters. Now it's the pharmaceutical industry that's turning to modular to provide "pop up" facilities to produce the needed vaccines to help control the COVID-19 pandemic.
If vaccines weren’t an increasing market before 2020, they most definitely are now. Designing a vaccine-specific facility solution that is not only quick to market but can stand the test of time is more important than ever.
Availability of engineering capacity and expertise in planning, designing, and executing the projects are some of the challenges when establishing these complex facilities. Another challenge is how to ensure that the facility you decide to build will be flexible enough and can be adapted to future changes in the product mix. Time to market and ensuring the return of investment are also key for a successful capital investment project.
Vaccine companies, like pharmaceutical manufacturers, desire innovative facility solutions to address these challenges. To this end, modular facilities can be an attractive solution.
CLICK HERE to read the entire Cleanroom Technology article
Sign Up to receive the Modcoach News newsletter twice a week